Reliance, Wipro lift stock market as hopes of Covid vaccine boost optimism

India's most valuable stock Reliance Industries rose about 1.1% ahead of an annual general meeting due later in the day

markets, stock market, sensex, nifty
Among sectors, The Nifty IT index gained 2.89% and the Nifty banking index rose 0.8%.
Reuters Bengaluru
2 min read Last Updated : Jul 15 2020 | 11:32 AM IST

Indian shares gained almost 1% on Wednesday as hopes for the swift launch of Covid-19 vaccines lifted stock markets across Asia, while upbeat results for IT outsourcer Wipro and signs of new foreign investment inflows countered fears about the surge in domestic coronavirus cases.

India's most valuable stock Reliance Industries rose about 1.1% ahead of an annual general meeting due later in the day after Bloomberg reported on Tuesday that Alphabet Inc's Google was in advanced talks to invest $4 billion in the digital arm of the conglomerate.

ALSO READ: MARKET LIVE: Sensex zooms 600 points, Nifty tops 10,750; Wipro surges 15%

Wipro rose 10%, topping the Nifty 50 blue-chip index, after reporting a better-than-expected profit for the three months ended June 30 along with the acquisition of Brazil-based IVIA Servicos De Informatica Ltd.

Larger rival Infosys, which is expected to report first-quarter results Wednesday evening, gained as much as 3.4% after it announced a partnership with U.S.-based investment management firm Vanguard late on Tuesday.

By 0350 GMT both the blue chip index rose and the broader S&P BSE Sensex were up around 0.9% at to 10,702.95 and 36,360.99 respectively.

Among sectors, The Nifty IT index gained 2.89% and the Nifty banking index rose 0.8%.

 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineIndian marketsNifty 50Nifty stocksRIL stockWipro results

Next Story